Sionna Therapeutics (SION) Other financing activities (2024 - 2026)
Sionna Therapeutics' (SION) quarterly Other financing activities came in at $320000.0 in Q1 2026, down 77.67% quarter-over-quarter from $1.4 million in Q4 2024.
Sionna Therapeutics (SION) Other financing activities (2024 - 2026) Analysis & Trends
Sionna Therapeutics has disclosed Other financing activities across 2 years of filings, most recently posting $320000.0 for Q1 2026.
- Other financing activities for Q1 2026 came in at $320000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (changed N/A YoY), and the FY2024 annual result was $2.5 million, changed N/A from the prior year.
- Other financing activities came in at $320000.0 for Q1 2026 at Sionna Therapeutics, down from $1.4 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.4 million in Q4 2024 to a low of $320000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Sionna Therapeutics | 1.61 Bn | 1.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 320,000.00 |
| Mar 31, 2026 | 320,000.00 |
| Dec 31, 2024 | 1.43 Mn |
| Dec 31, 2024 | 1.43 Mn |
| Mar 31, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |